Search
Microsoft's AI for Health division has introduced MAI-DxO, a groundbreaking medical AI tool that surpasses human doctors in diagnosing complex diseases with a success rate four times higher. At its heart lies a sophisticated coordinator that assembles a virtual expert panel comprising five agents. These agents work in tandem through a "debate chain" technology to devise precise treatment plans. In rigorous testing, MAI-DxO achieved a remarkable success rate of 85.5% in resolving cases, starkly contrasting with human doctors' 20% success rate. While the technology has yet to undergo peer review or clinical application, it has already demonstrated substantial benefits in minimizing examination items and diagnostic costs. Experts recommend the next step to be comparative trials in real-world clinical environments to fully assess its practical utility and value.
-
C114 Communication Network -
Communication Home
